COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,845 Articles (22,553 medRxiv, 8,292 bioRxiv)

Most recent first Previous |  Page 1332: Articles 13311-13320  | Next

Estimating the effectiveness of first dose of COVID-19 vaccine against mortality in England: a quasi-experimental study
Bermingham, C., Morgan, J., Ayoubkhani, D., Glickman, M., Islam, N., Sheikh, A., Sterne, J., Walker, A. S., Nafilyan, V.
10.1101/2021.07.12.21260385 — Posted: 2021-07-16
Impact of BNT162b2 vaccination and isolation on SARS-CoV-2 transmission in Israeli households: an observational study
Layan, M., Gilboa, M., Gonen, T., Goldenfeld, M., Meltzer, L., Andronico, A., Hoze, N., Cauchemez, S., Regev-Yochay, G.
10.1101/2021.07.12.21260377 — Posted: 2021-07-16 Discussion: Onsite
Global and regional prevalence and outcomes of COVID-19 in people living with HIV: A systematic review and meta-analysis
Raya, R. P., Kamila, A., Alqahtani, J. S., Hjazi, A. M., Li, A., Oyelade, T.
10.1101/2021.07.12.21260361 — Posted: 2021-07-16
Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2
Galipeau, Y., Siragam, V., Laroche, G., Marion, E., Greig, M., McGuinty, M., Booth, R., Durocher, Y., Cuperlovic-Culf, M., Bennett, S. L., Crawley, A. M., Giguere, P., Cooper, C., Langlois, M.-A.
10.1101/2021.07.16.21260079 — Posted: 2021-07-16
Contamination of personal protective equipment during COVID-19 autopsies
Brandner, J. M., Boor, P., Borcherding, L. S., Edler, C., Gerber, S., Heinemann, A., Hilsenbeck, J., Kasajima, A., Lohner, L., Märkl, B., Pablik, J., Schröder, A. S., Sommer, L., Slotta-Huspenina, J., Sperhake, J.-P., von Stillfried, S., Dintner, S.
10.1101/2021.07.12.21260357 — Posted: 2021-07-15
The temporal correlation between positive testing and death in Italy: from the first phase to the later evolution of the COVID-19 pandemic
d'Alessandro, V., Balasco, N., Ferrara, P., Vitagliano, L.
10.1101/2021.07.14.21260505 — Posted: 2021-07-15
Characterization of long-term patient-reported symptoms of COVID-19: an analysis of social media data
Banda, J. M., Adderley, N., Ahmed, W.-U.-R., AlGhoul, H., Alser, O., Alser, M., Areia, C., Cogenur, M., Fister, K., Gombar, S., Huser, V., Jonnagaddala, J., Lai, L., Leis, A., Mateu, L., Mayer, M. A., Minty, E., Morales, D. R., Natarajan, K., Paredes, R., Periyakoil, V. S., Prats-Uribe, A., Ross, E. G., Singh, G. V., Subbian, V., Vivekanantham, A., Prieto-Alhambra, D.
10.1101/2021.07.13.21260449 — Posted: 2021-07-15
Pre-existing antibodies targeting a dominant linear antibody epitope on SARS-CoV-2 S2 cross-reacted with commensal gut bacteria and shaped immune responses elicited by a candidate vaccine
Jia, L., Weng, S., Wu, J., Tian, X., Zhang, Y., Wang, X., Wang, J., Yan, D., Wang, W., Zhu, Z., Qiu, C., Zhang, W., Xu, Y., Wan, Y.
10.1101/2021.07.13.21260404 — Posted: 2021-07-15
Detection and whole-genome sequencing of SARS-CoV-2 B.1.617.2 and B.1.351 variants of concern from Pakistan during the COVID-19 third wave
Umair, M., Ikram, A., Salman, M., Badar, N., Haider, S. A., Rehman, Z., Ammar, M., Rana, M. S., Ali, Q.
10.1101/2021.07.14.21259909 — Posted: 2021-07-15
Prospective, Randomized, Parallel-Group, Open-Label Study to Evaluate the Efficacy and Safety of IMU-838, in Combination with Oseltamivir, in Adults with Coronavirus Disease 19 The IONIC Trial
Sharma, K., Berry, D. L., Vryonis, D. E., Ali, D. A., Lara, D. B., Noufaily, D. A., Parsons, D. N., Bradley, C. J., Haley, B., Tabuso, M., Arasaradnam, P. R.
10.1101/2021.07.13.21258757 — Posted: 2021-07-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).